Feb. 2 at 2:11 PM
Premarket movers 📈
Upside:
$AQST +39% — FDA CRL issued; resubmission expected in 3Q26
$HAIN +12% — selling North American snacks business
$CATX +11% —
$175M equity offering priced
$HROW +9.4% — FY25 outlook reaffirmed; MELT-300 on track
$TWST +7.1% — earnings and guidance
NSSC +5.7% — earnings, dividend hike
MLTX +5.4% — FDA Fast Track designation
ORCL +3.9% — equity distribution and preferred share offering
PLTR +2.1% — analyst upgrade
RVTY +2.0% — earnings
Downside:
YEXT -22% — CEO pulls buyout bid;
$150M self-tender planned
